Journals of Gerontology Series A: Biological Sciences and Medical Sciences, Vol 52, Issue 2 M76-M79, Copyright © 1997 by The Gerontological Society of America

JOURNAL ARTICLE

Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?

E Joosten, E Lesaffre, R Riezler, V Ghekiere, L Dereymaeker, W Pelemans and E Dejaeger
Department of Pathophysiology, University Hospitals K. U. Leuven, Belgium.

BACKGROUND: It is still unclear whether there is an association between Alzheimer's disease and vitamin B-12 or folate deficiency. This study was designed to investigate whether patients with Alzheimer's disease are particularly prone to metabolically significant cobalamin or folate deficiency as compared to nondemented hospitalized controls and healthy elderly controls living at home. METHODS: Evaluation for the diagnosis of Alzheimer's disease, routine laboratory tests, serum folate and vitamin B-12, serum methylmalonic acid (MMA), total homocysteine (tHcy), and radiological tests was performed in 52 patients with Alzheimer's disease (AD), 50 nondemented hospitalized controls, and 49 healthy elderly subjects living at home. RESULTS: Serum vitamin B-12 and folate levels are comparable between patients with AD, hospitalized control patients, and subjects living at home. Patients with AD have the highest serum MMA and tHcy levels. The MMA levels of patients with AD and hospitalized controls are not different, but the mean tHcy level is significantly higher in patients with AD as compared to nondemented patients or subjects living at home. CONCLUSION: The interpretation of the vitamin B-12 and folate status in patients with AD depends largely on the methodology (i.e., serum vitamin vs metabolite levels) and the selection of the control group. Although patients with AD have the highest tHcy and MMA levels, metabolically significant vitamin B-12 and folate deficiency is also a substantial problem in nondemented elderly patients.

This article has been cited by other articles: (Search Google Scholar for Other Citing Articles)

				W. Reynish, S. Andrieu, F. Nourhashemi, and B. Vellas Nutritional Factors and Alzheimer's Disease J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2001; 56(11): M675 - 680. [Abstract] [Full Text] [PDF]

				M. A. Medina, J. L. Urdiales, and M. I. Amores-Sanchez Roles of homocysteine in cell metabolism: Old and new functions FEBS J., July 15, 2001; 268(14): 3871 - 3882. [Abstract] [Full Text] [PDF]

				H-X. Wang, A. Wahlin, H. Basun, J. Fastbom, B. Winblad, and L. Fratiglioni Vitamin B12 and folate in relation to the development of Alzheimer's disease Neurology, May 8, 2001; 56(9): 1188 - 1194. [Abstract] [Full Text] [PDF]

				K. Nilsson, L. Gustafson, and B. Hultberg The Plasma Homocysteine Concentration Is Better Than That of Serum Methylmalonic Acid as a Marker for Sociopsychological Performance in a Psychogeriatric Population Clin. Chem., May 1, 2000; 46(5): 691 - 696. [Abstract] [Full Text] [PDF]

				J. Selhub, L. C Bagley, J. Miller, and I. H Rosenberg B vitamins, homocysteine, and neurocognitive function in the elderly1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 614s - 620s. [Abstract] [Full Text] [PDF]

				F. Nourhashemi, S. Gillette-Guyonnet, S. Andrieu, A. Ghisolfi, P. J. Ousset, H. Grandjean, A. Grand, J. Pous, B. Vellas, and J.-L. Albarede Alzheimer disease: protective factors1 Am. J. Clinical Nutrition, February 1, 2000; 71(2): 643s - 649s. [Abstract] [Full Text] [PDF]

				J Gussekloo, B T Heijmans, P E Slagboom, A M Lagaay, D L Knook, and R G J Westendorp Thermolabile methylenetetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85 J. Neurol. Neurosurg. Psychiatry, October 1, 1999; 67(4): 535 - 538. [Abstract] [Full Text]